文献速递针灸推拿中医骨伤中医康复

药针疗法与物理疗法治疗慢性下腰痛的成本-效用分析:多中心实用随机对照试验

A cost-utility analysis of pharmacopuncture versus physiotherapy for chronic low back pain: A multicenter, pragmatic randomized controlled trial.
PubMed 文献 · Integr Med Res · 2025-08-05

本研究为多中心两臂随机对照试验,纳入100例慢性下腰痛患者,比较药针疗法(PPT)与物理疗法(PT)的成本-效用。从社会视角看PPT总成本更低且QALY更高;从医疗系统视角PPT的ICER为每QALY 16,575美元,具成本效果。敏感性分析证实结果稳健。

要点

  • 药针疗法较物理疗法在慢性下腰痛中具成本效果优势。
  • 社会视角下药针疗法总成本更低且QALY改善更优。
  • 医疗系统视角ICER为16,575美元/QALY。

核心结论

  • 药针疗法可能是慢性下腰痛相对于常规物理疗法的具成本效果替代方案。
  • 建议需更大样本量和更长随访研究验证结果。

研究设计与样本

  • 多中心两臂随机对照试验,纳入100例慢性下腰痛患者。
  • 患者随机分入药针疗法组或物理疗法组,五周内接受10次治疗。

主要发现

  • 社会视角下药针疗法总体成本更低且QALY更高。
  • 医疗系统视角下药针疗法的ICER为每QALY 16,575美元,提示具成本效果。
  • 敏感性分析证实上述发现的稳健性。

关键数值与推荐

  • 效用采用EQ-5D-5L量表计算QALY。
  • 成本从医疗系统和社会视角评估,含医疗成本与生产力损失。
  • 生产力损失采用WPAI问卷评估。
  • ICER通过两组成本差异除以QALY差异计算。

临床怎么用

  • 临床决策中可将药针疗法作为慢性下腰痛的非药物整合治疗选项之一。
  • 从社会视角评估时药针疗法可能更具经济优势。

局限性

  • 样本量为100例,作者建议需更大样本量研究验证。
  • 作者建议需延长随访以确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic low back pain (cLBP) is a significant global health issue, contributing to disability and economic strain. Nonpharmacological treatments, such as acupuncture and integrative approaches like pharmacopuncture (PPT), have shown potential in alleviating the burden of cLBP. This study aimed to evaluate the cost-effectiveness of PPT compared to physical therapy (PT) for managing cLBP from both healthcare system and societal perspectives. METHODS: A multicenter, two-arm randomized controlled trial was conducted, involving 100 patients with cLBP. Patients were randomized into either the PPT group or the PT group, receiving 10 treatment sessions over five weeks. Utility was measured using the EuroQol 5-Dimension 5-Level scale (EQ-5D-5L) to calculate quality-adjusted life years (QALYs), and costs were evaluated from healthcare and societal perspectives, including medical costs and productivity loss. Productivity loss was assessed using the Work Productivity and Activity Impairment (WPAI) questionnaire. Incremental cost-effectiveness ratios (ICERs) were calculated by dividing the differences in costs by the differences in QALYs between the two groups. Bootstrapping and sensitivity analyses were performed to assess robustness. RESULTS: PPT was more cost-effective than PT, particularly from a societal perspective where it demonstrated lower overall costs and improved QALY. From a healthcare system perspective, the ICER of PPT was 16,575 USD per QALY, indicating cost-effectiveness. Sensitivity analyses confirmed the robustness of these findings. CONCLUSION: This study highlights PPT as a potentially cost-effective alternative to conventional PT for cLBP, though further research with larger sample sizes and extended follow-up is recommended to validate these results. TRIAL REGISTRATION: ClinicalTrials.gov (NCT04833309), Clinical Research Information Service (KCT0006088).

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Lee YS, Kim SJ, Park KS, et al. A cost-utility analysis of pharmacopuncture versus physiotherapy for chronic low back pain: A multicenter, pragmatic randomized controlled trial. Integr Med Res. 2025. PMID: 41497196. doi:10.1016/j.imr.2025.101210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。